BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 8, 2004
View Archived Issues
Starting With 'Smaller, Perfect Pieces' To Make Larger Genes
Read More
Series C Round Brings In $11M To Antiviral Developer Chimerix
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
VaxGen Wins $878M BioShield Contract For Anthrax Vaccine
Just a few days after the re-election of President Bush, the U.S. government awarded VaxGen Inc. an $877.5 million contract to supply anthrax vaccine for civilian defense. (BioWorld Today)
Read More
Inhibitex Finishes IPO Job: Placement Brings In $50M
Read More